2022 annual financial data
Ovid Therapeutics 2022 Operating margin
Direct answer
Operating margin was -3,696.44%.
Operating income was -55,548,161 USD and net income was -51,408,292 USD.
Operating cash flow was -55,227,127 USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,502,748 USD
- Operating income
- -55,548,161 USD
- Net income
- -51,408,292 USD
- Operating cash flow
- -55,227,127 USD